{"doi":"10.1159/000252130","title":"Fixed Drug Eruption to Oxyphenbutazone and Phenylbutazone","abstract":"<jats:p>In the literature there is only one report of a fixed drug eruption due to oxyphenbutazone. We are reporting a patient whose fixed drug eruption was caused by oxyphenbutazone and who showed cross-sensitivity to phenylbutazone. There was no history of phenylbutazone having been administered to this patient earlier than the challenging test dose.</jats:p>","journal":"Dermatologica","year":2009,"id":43061,"datarank":8.126187713017849,"base_score":3.1780538303479458,"endowment":3.1780538303479458,"self_citation_contribution":0.47670807455219194,"citation_network_contribution":7.649479638465657,"self_endowment_contribution":0.47670807455219194,"citer_contribution":7.649479638465657,"corpus_percentile":null,"corpus_rank":null,"citation_count":23,"citer_count":21,"citers_with_citation_signal":21,"citers_with_endowment":21,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":205194,"name":"J.S. Pasricha","orcid":null,"position":1,"is_corresponding":false},{"id":205193,"name":"K.C. Nayyar","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":3.1780538303479458,"endowment":3.1780538303479458,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"5076722","pmcid":null,"openalex_id":"https://openalex.org/W1995395695","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.10461581,"influential_citations":0,"citation_trend":[{"year":2022,"count":1},{"year":2024,"count":1}],"oa_status":"closed","license":"https://karger.com/pages/terms-and-conditions","oa_locations":[{"url":"https://www.karger.com/Article/Pdf/252130","host_type":"publisher"},{"url":"https://karger.com/article-pdf/doi/10.1159/000252130","host_type":"publisher"},{"url":"https://doi.org/10.1159/000252130","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/5076722","host_type":"repository"}],"fields_of_study":["Drug-Induced Adverse Reactions","Pharmacovigilance and Adverse Drug Reactions","Blood disorders and treatments","Medicine","Adult","Drug Hypersensitivity","Erythema","Female","Humans","Oxyphenbutazone","Phenylbutazone","Pruritus","Structure-Activity Relationship"],"mesh_terms":["Adult","Drug Hypersensitivity","Erythema","Female","Humans","Oxyphenbutazone","Phenylbutazone","Pruritus","Structure-Activity Relationship"],"keywords":["Oxyphenbutazone","Phenylbutazone","Medicine","Drug","Dermatology","Surgery","Pharmacology"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-14T15:02:07.154564Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}